Hyperfine (HYPR) Non-Current Deffered Revenue (2021 - 2026)
Hyperfine's (HYPR) quarterly Non-Current Deffered Revenue came in at $713000.0 in Q1 2026, down 30.64% YoY from $1.0 million in Q1 2025, and down 2.19% on a QoQ basis from $729000.0 in Q4 2025.
Hyperfine (HYPR) Non-Current Deffered Revenue (2021 - 2026) Analysis & Trends
Hyperfine (HYPR) has 6 years of Non-Current Deffered Revenue data on file, last reported at $713000.0 in Q1 2026.
- Quarterly Non-Current Deffered Revenue fell 30.64% year-over-year to $713000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $713000.0 (down 30.64% YoY) and the FY2025 annual result came in at $729000.0, down 30.83% from the prior year.
- Non-Current Deffered Revenue declined to $713000.0 in Q1 2026, from $729000.0 in the prior quarter.
- In the past five years, Non-Current Deffered Revenue ranged from a high of $1.5 million in Q4 2022 to a low of $713000.0 in Q1 2026.
- A 5-year average of $1.0 million and a median of $1.0 million in 2024 frame the typical range for Non-Current Deffered Revenue.
- Annual changes were most pronounced in 2022 — Non-Current Deffered Revenue soared 199.22% — and 2023, when it sank 36.57%.
- Tracing HYPR's Non-Current Deffered Revenue over 5 years: stood at $1.5 million in 2022, then slumped by 36.57% to $968000.0 in 2023, then climbed by 8.88% to $1.1 million in 2024, then tumbled by 30.83% to $729000.0 in 2025, then retreated by 2.19% to $713000.0 in 2026.
- The last three Non-Current Deffered Revenue figures came in at $713000.0 (Q1 2026), $729000.0 (Q4 2025), and $974000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Deffered Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 202.72 Bn | 197.12 Bn | 7.27 Bn | - |
| 2 | Stryker | 126.42 Bn | 122.94 Bn | 4.50 Bn | - |
| 3 | Medtronic | 119.75 Bn | 110.53 Bn | 6.41 Bn | - |
| 4 | Boston Scientific | 74.13 Bn | 73.60 Bn | 3.85 Bn | - |
| 5 | Edwards Lifesciences | 51.78 Bn | 47.53 Bn | 1.35 Bn | - |
| 6 | Dexcom | 35.29 Bn | 33.34 Bn | 830.00 Mn | - |
| 7 | GE HealthCare Technologies | 33.95 Bn | 31.85 Bn | 2.18 Bn | - |
| 8 | Koninklijke Philips | 26.22 Bn | 22.90 Bn | 4.55 Bn | 539.34 Mn |
| 9 | Steris | 23.21 Bn | 22.73 Bn | 684.20 Mn | - |
| 10 | Hyperfine | 89.83 Mn | 45.06 Mn | 1.98 Mn | 835,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 835,000.00 |
| Mar 31, 2026 | 713,000.00 |
| Dec 31, 2025 | 729,000.00 |
| Sep 30, 2025 | 974,000.00 |
| Jun 30, 2025 | 914,000.00 |
| Mar 31, 2025 | 1.03 Mn |
| Dec 31, 2024 | 1.05 Mn |
| Sep 30, 2024 | 1.11 Mn |
| Jun 30, 2024 | 1.06 Mn |
| Mar 31, 2024 | 1.02 Mn |
| Dec 31, 2023 | 968,000.00 |
| Sep 30, 2023 | 1.09 Mn |
| Jun 30, 2023 | 1.28 Mn |
| Mar 31, 2023 | 1.36 Mn |
| Dec 31, 2022 | 1.53 Mn |
| Sep 30, 2022 | 889,000.00 |
| Jun 30, 2022 | 745,000.00 |
| Mar 31, 2022 | 851,000.00 |
| Dec 31, 2021 | 510,000.00 |